T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1
- Author
- Jens Staal (UGent) , Yasmine Driege (UGent) , Tine Bekaert (UGent) , Annelies Demeyer (UGent) , David Muyllaert (UGent) , Petra Van Damme (UGent) , Kris Gevaert (UGent) and Rudi Beyaert (UGent)
- Organization
- Project
- Abstract
- The paracaspase mucosa-associated lymphoid tissue 1 (MALT1) is central to lymphocyte activation and lymphomagenesis. MALT1 mediates antigen receptor signalling to NF-kappa B by acting as a scaffold protein. Furthermore, MALT1 has proteolytic activity that contributes to optimal NF-kappa B activation by cleaving the NF-kappa B inhibitor A20. Whether MALT1 protease activity is involved in other signalling pathways, and the identity of the relevant substrates, is unknown. Here, we show that T-cell receptors (TCR) activation, as well as overexpression of the oncogenic API2-MALT1 fusion protein, results in proteolytic inactivation of CYLD by MALT1, which is specifically required for c-jun N-terminal kinase (JNK) activation and the inducible expression of a subset of genes. These results indicate a novel role for MALT1 proteolytic activity in TCR-induced JNK activation and reveal CYLD cleavage as the underlying mechanism.
- Keywords
- signal transduction, ubiquitination, NF-KAPPA-B, UBIQUITIN-DEPENDENT KINASE, CYTOKINE PRODUCTION, DEUBIQUITINATING ENZYME CYLD, TUMOR-SUPPRESSOR CYLD, CARMA3/BCL10/MALT1 COMPLEX, SIGNALING PATHWAY, NEGATIVE REGULATION, TAK1, PROTEIN, MAP kinase, cytokine, AP-1
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 1.77 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-1887628
- MLA
- Staal, Jens, et al. “T-Cell Receptor-Induced JNK Activation Requires Proteolytic Inactivation of CYLD by MALT1.” EMBO JOURNAL, vol. 30, no. 9, 2011, pp. 1742–52, doi:10.1038/emboj.2011.85.
- APA
- Staal, J., Driege, Y., Bekaert, T., Demeyer, A., Muyllaert, D., Van Damme, P., … Beyaert, R. (2011). T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1. EMBO JOURNAL, 30(9), 1742–1752. https://doi.org/10.1038/emboj.2011.85
- Chicago author-date
- Staal, Jens, Yasmine Driege, Tine Bekaert, Annelies Demeyer, David Muyllaert, Petra Van Damme, Kris Gevaert, and Rudi Beyaert. 2011. “T-Cell Receptor-Induced JNK Activation Requires Proteolytic Inactivation of CYLD by MALT1.” EMBO JOURNAL 30 (9): 1742–52. https://doi.org/10.1038/emboj.2011.85.
- Chicago author-date (all authors)
- Staal, Jens, Yasmine Driege, Tine Bekaert, Annelies Demeyer, David Muyllaert, Petra Van Damme, Kris Gevaert, and Rudi Beyaert. 2011. “T-Cell Receptor-Induced JNK Activation Requires Proteolytic Inactivation of CYLD by MALT1.” EMBO JOURNAL 30 (9): 1742–1752. doi:10.1038/emboj.2011.85.
- Vancouver
- 1.Staal J, Driege Y, Bekaert T, Demeyer A, Muyllaert D, Van Damme P, et al. T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1. EMBO JOURNAL. 2011;30(9):1742–52.
- IEEE
- [1]J. Staal et al., “T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1,” EMBO JOURNAL, vol. 30, no. 9, pp. 1742–1752, 2011.
@article{1887628, abstract = {{The paracaspase mucosa-associated lymphoid tissue 1 (MALT1) is central to lymphocyte activation and lymphomagenesis. MALT1 mediates antigen receptor signalling to NF-kappa B by acting as a scaffold protein. Furthermore, MALT1 has proteolytic activity that contributes to optimal NF-kappa B activation by cleaving the NF-kappa B inhibitor A20. Whether MALT1 protease activity is involved in other signalling pathways, and the identity of the relevant substrates, is unknown. Here, we show that T-cell receptors (TCR) activation, as well as overexpression of the oncogenic API2-MALT1 fusion protein, results in proteolytic inactivation of CYLD by MALT1, which is specifically required for c-jun N-terminal kinase (JNK) activation and the inducible expression of a subset of genes. These results indicate a novel role for MALT1 proteolytic activity in TCR-induced JNK activation and reveal CYLD cleavage as the underlying mechanism.}}, author = {{Staal, Jens and Driege, Yasmine and Bekaert, Tine and Demeyer, Annelies and Muyllaert, David and Van Damme, Petra and Gevaert, Kris and Beyaert, Rudi}}, issn = {{0261-4189}}, journal = {{EMBO JOURNAL}}, keywords = {{signal transduction,ubiquitination,NF-KAPPA-B,UBIQUITIN-DEPENDENT KINASE,CYTOKINE PRODUCTION,DEUBIQUITINATING ENZYME CYLD,TUMOR-SUPPRESSOR CYLD,CARMA3/BCL10/MALT1 COMPLEX,SIGNALING PATHWAY,NEGATIVE REGULATION,TAK1,PROTEIN,MAP kinase,cytokine,AP-1}}, language = {{eng}}, number = {{9}}, pages = {{1742--1752}}, title = {{T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1}}, url = {{http://doi.org/10.1038/emboj.2011.85}}, volume = {{30}}, year = {{2011}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: